{"organizations": [], "uuid": "295c7164a31b6c1d1c1436f27d3a299bc139afc2", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180114.html", "section_title": "Archive News &amp; Video for Sunday, 14 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-egypts-memphis-pharmaceuticals-pos/brief-egypts-memphis-pharmaceuticals-posts-h1-loss-idUSFWN1P7127", "country": "US", "domain_rank": 408, "title": "BRIEF-Egypt's Memphis Pharmaceuticals Posts H1 Loss", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.994, "site_type": "news", "published": "2018-01-14T16:00:00.000+02:00", "replies_count": 0, "uuid": "295c7164a31b6c1d1c1436f27d3a299bc139afc2"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-egypts-memphis-pharmaceuticals-pos/brief-egypts-memphis-pharmaceuticals-posts-h1-loss-idUSFWN1P7127", "ord_in_thread": 0, "title": "BRIEF-Egypt's Memphis Pharmaceuticals Posts H1 Loss", "locations": [], "entities": {"persons": [], "locations": [{"name": "memphis", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "memphis pharmaceuticals posts", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 14 (Reuters) - MEMPHIS PHARMACEUTICALS AND CHEMICAL INDUSTRIES:\n* H1 NET LOSS EGP 18.4 ‍​MILLION VERSUS PROFIT OF EGP 2.4 ‍​MILLION YEAR AGO Source: ( bit.ly/2mAAH9I ) Further company coverage:\n ", "external_links": ["http://bit.ly/2mAAH9I", "http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-14T16:00:00.000+02:00", "crawled": "2018-01-15T16:53:32.000+02:00", "highlightTitle": ""}